Certified by Founder Lodge
Axonis Therapeutics
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $115,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibitory neurotransmission
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 31 ,2024 | Series A | $115,000,000 |
Solasta Ventures
Perceptive Advisors
Sofinnova Investments
Lumira Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
MaiaEdge | $20,000,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
ecovia I bio | Undisclosed Amount | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
